Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Low dose HP-hMG in an antagonist protocol for IVF in ovulatory and anovulatory patients with high AMH

Research output: Contribution to journalJournal articleResearchpeer-review

  1. The impact of gastric bypass surgery on sex hormones and menstrual cycles in premenopausal women

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Atrial natriuretic peptide, copeptin and adrenomedullin levels in polycystic ovary syndrome: a case-control study

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Left-right differences in ovarian volume and antral follicle count in 1423 women of reproductive age

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Selective use of corifollitropin for controlled ovarian stimulation for IVF in patients with low anti-Müllerian hormone

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Endogenous thrombin potential in polycystic ovary syndrome: the association to body mass index, insulin resistance, and inflammation

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Cumulative live birth rate prognosis based on the number of aspirated oocytes in previous ART cycles

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. A randomized controlled trial of AMH-based individualized FSH dosing in a GnRH antagonist protocol for IVF

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Status one year after fertility assessment and counselling in women of reproductive age-a qualitative study

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Autotransplantation of fragmented ovarian cortical tissue: a laparoscopic demonstration

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Women with high-AMH levels have an increased risk of ovarian hyperstimulation syndrome (OHSS). Studies have suggested that highly purified menotropin (HP-hMG) Menopur® reduces the risk. We, therefore, studied use of low-dose (112.5 IU/day) HP-hMG in ovulatory and anovulatory patients with high AMH (>32 pmol/L). The primary endpoint was the distribution of patients with appropriate, excessive, and inadequate response (5-14, ≥15, and ≤4 oocytes). Another endpoint was frequency of OHSS. Totally 115 women were included and 78 (67.8%) had an appropriate, 8 (7.0%) an excessive, and 29 (25.2%) an inadequate response. The number of oocytes was independent on AMH levels and ovulatory status but declined significantly with increasing bodyweight (R2 = 0.07, p < .01). The ongoing pregnancy rate per started cycle was 47.0%. Three (2.6%) developed OHSS, two had cancelation of the cycle and seven patients had GnRH agonist triggering to prevent OHSS. Selective use of a low dose of HP-hMG in patients with high levels of AMH provides 5-14 oocytes in more than two-thirds of the patients and is safe with low risk of OHSS. The number of aspirated oocytes was independent of AMH levels and ovulatory status, but inversely related to body weight.

Original languageEnglish
JournalGynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology
Volume34
Issue number7
Pages (from-to)623-626
Number of pages4
ISSN0951-3590
DOIs
Publication statusPublished - Jul 2018

    Research areas

  • Adult, Anovulation/blood, Anti-Mullerian Hormone/blood, Dose-Response Relationship, Drug, Female, Fertilization in Vitro/methods, Gonadotropin-Releasing Hormone/antagonists & inhibitors, Hormone Antagonists/administration & dosage, Humans, Menotropins/administration & dosage, Ovarian Hyperstimulation Syndrome/prevention & control, Ovulation/blood, Ovulation Induction/methods, Pregnancy, Pregnancy Rate

ID: 56415280